News in the Life Sciences Industry

STOCKHOLM, Aug. 5, 2020 /PRNewswire/ -- Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) has published results from a meta study that demonstrates a highly significant and clinically relevant effect of Diamyd Medical's lead drug candidate Diamyd(®)... Read more ››

GOTHENBURG, Sweden, Aug. 4, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier... Read more ››

STOCKHOLM, Aug. 4, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announced that the first patient has been enrolled in the phase 2 PORT study. The study, which is expected to be fully recruited in December 2020, is an open-label, randomized, cross-over study which... Read more ››

STOCKHOLM, Aug. 4, 2020 /PRNewswire/ -- On August 11(th), 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for July 2019 - June 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same... Read more ››

STOCKHOLM, Aug. 3, 2020 /PRNewswire/ -- IRLAB announced today that the World Health Organization (WHO) has proposed the name pirepemat as the International Nonproprietary Name (INN) for the company's drug candidate IRL752, which is in development for decreasing the risk of falling in patients... Read more ››

STOCKHOLM, July 31, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed as a result of shares being registered due to the directed share issue which was carried out in May 2020 and due to the exercise... Read more ››

LUND, Sweden, July 31, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announces that the Company' s registered share capital and number of outstanding shares and votes have increased during the month of July.

STOCKHOLM, July 31, 2020 /PRNewswire/ -- The number of shares and votes in Cantargia AB (publ) has changed due to the company's Chairman of the Board, Magnus Persson, exercising his right to subscribe for shares in accordance with the 2017/2020 warrant program. Through the exercise of the warrants,... Read more ››

STOCKHOLM, July 31, 2020 /PRNewswire/ -- SECOND QUARTER 2020

STOCKHOLM, July 30, 2020 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces the appointment of Dr Cindy Wong as Chief Medical Officer of Moberg Pharma. Dr Wong will during the fall be joining the management team at Moberg Pharma coming from a previous position as Vice President and Head... Read more ››

STOCKHOLM, July 30, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company's partner Eisai presented the latest data from the open-label extension of the Phase 2b study with the investigational BAN2401 in early Alzheimer's disease. The preliminary... Read more ››